Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)

A. Von Drygalski, A. Giermasz, G. Castaman

Research output: Contribution to journalComment/debatepeer-review

Abstract

A copy of the article's visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.

Original languageEnglish (US)
Pages (from-to)3668
Number of pages1
JournalBlood Advances
Volume4
Issue number15
DOIs
StatePublished - Aug 11 2020

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)'. Together they form a unique fingerprint.

Cite this